Moore J W, Clark G M, Bulbrook R D, Hayward J L, Murai J T, Hammond G L, Siiteri P K
Int J Cancer. 1982 Jan 15;29(1):17-21. doi: 10.1002/ijc.2910290105.
In premenopausal women with breast cancer, total serum oestradiol (E2) concentrations are normal but nonprotein-bound E2 concentration are significantly raised. This is not due to low sex-hormone-binding-globulin (SHBG) binding capacities which are within the normal range and is unlikely to be due to the small but significant decrease in albumin concentrations. In post-menopausal patients, both total and non-protein-bound E2 are significantly raised: this may be explained partially by lower SHBG binding capacities. In patients and controls there is a highly significant correlation between non-protein-bound E2 and SHBG but, for a given SHBG binding capacity, the patients have more non-bound E2 than controls. It is concluded that the breast in women with breast cancer may be exposed to elevated levels of biologically active E2 although the reasons for this remain obscure.
在绝经前乳腺癌女性中,血清总雌二醇(E2)浓度正常,但非蛋白结合型E2浓度显著升高。这并非由于性激素结合球蛋白(SHBG)结合能力低下(其处于正常范围内),也不太可能是由于白蛋白浓度虽有小幅但显著的下降。在绝经后患者中,总E2和非蛋白结合型E2均显著升高:这可能部分归因于较低的SHBG结合能力。在患者和对照组中,非蛋白结合型E2与SHBG之间存在高度显著的相关性,但对于给定的SHBG结合能力,患者的非结合型E2比对照组更多。得出的结论是,乳腺癌女性的乳腺可能暴露于生物活性E2水平升高的环境中,尽管其原因仍不清楚。